Deep Dive: Mission Cancer – Last Calls in Horizon Europe | Insights into topics and experiences from a running project

For the upcoming last 2 Calls in the Mission Cancer Programme, different topics are available, covering the entire Mission pipeline and ranging from understanding the disease, diagnostics, treatment options until quality of life for patients, carers and families affected.

In this session, we will inform you about details and provide background information for the upcoming Calls. Sabine Taschner-Mandl from CCRI, St. Anna Kinderkrebsforschung, a representative from the running “Mission Cancer” project MONALISA, will give us insights and share her experiences. We will also explain what makes the difference in these projects in comparison to the ones under “Cluster 1 Health”, lessons learned from previous Calls and what you can expect in the upcoming Framework Programme “FP10/Horizon Europe” for the Missions.

Agenda:

• Introduction and overview

• Mission Cancer – Insights into Calls 2026 and 2027

• Lessons learned from previous calls & statistics

• Success Story: experiences from the running project MONALISA

• Outlook Mission Cancer in “FP10” – what’s coming next?

• Our support services for you  

• Q&A

Speakers:

Ines Haberl, National Contact Point Health, FFG
ines.haberl@ffg.at

Sabine Taschner-Mandl, CCRI – St. Anna Kinderkrebsforschung
sabine.taschner@ccri.at

Further Information:

https://www.ffg.at/europa/heu/cluster1
https://www.ffg.at/europa/heu/missions
https://ccri.at/neuroblastoma-liquid-biopsies-to-detect-relapse-of-childhood-cancer-early/